Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 303.87M | 307.69M | 325.67M | 353.39M | 329.70M | 266.00M |
Gross Profit | 218.82M | 228.70M | 241.81M | 263.07M | 247.31M | 201.60M |
EBITDA | 76.00M | 75.22M | 26.62M | 77.25M | 20.52M | 75.79M |
Net Income | 8.52M | 7.12M | -69.02M | 9.48M | -24.62M | 20.02M |
Balance Sheet | ||||||
Total Assets | 571.39M | 581.59M | 577.15M | 693.96M | 776.13M | 557.39M |
Cash, Cash Equivalents and Short-Term Investments | 89.11M | 96.62M | 82.62M | 108.66M | 126.27M | 101.36M |
Total Debt | 469.10M | 472.07M | 483.98M | 493.38M | 504.33M | 279.53M |
Total Liabilities | 626.91M | 639.99M | 653.21M | 663.53M | 707.07M | 444.71M |
Stockholders Equity | 433.51M | 429.48M | 411.06M | 479.90M | 508.27M | 517.17M |
Cash Flow | ||||||
Free Cash Flow | 50.24M | 53.03M | 21.84M | 61.21M | 27.20M | 63.94M |
Operating Cash Flow | 55.93M | 59.65M | 28.26M | 71.14M | 42.44M | 70.85M |
Investing Cash Flow | -5.14M | -5.88M | -5.64M | -11.50M | -194.92M | -17.53M |
Financing Cash Flow | -10.45M | -8.27M | -35.82M | -78.36M | 189.35M | -36.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $880.47M | ― | -52.95% | ― | 83.50% | 8.45% | |
67 Neutral | $328.69M | 19.03 | 2.01% | ― | -4.61% | ― | |
67 Neutral | $1.49B | ― | -6.44% | 2.10% | 6.69% | -137.52% | |
63 Neutral | $6.98B | 18.97 | -1.16% | 6.86% | 4.65% | -25.28% | |
59 Neutral | $424.86M | ― | -6.84% | ― | 2.47% | -74.15% | |
57 Neutral | $206.76M | ― | -23.11% | ― | 11.24% | 38.70% | |
44 Neutral | $412.83M | ― | -47.67% | ― | 2.36% | -23.60% |
On May 14, 2025, Re/Max Holdings held its Annual Meeting where stockholders voted on several key proposals. The stockholders elected Class III directors, approved executive compensation, amended the 2023 Omnibus Incentive Plan, and ratified Ernst & Young LLP as the independent registered public accounting firm for 2025.
The most recent analyst rating on (RMAX) stock is a Sell with a $9.00 price target. To see the full list of analyst forecasts on Re/Max Holdings stock, see the RMAX Stock Forecast page.